TriSalus Life Sciences, Inc.TriSalus Life Sciences, Inc.TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪275.67 M‬USD
−2.4197USD
‪−59.04 M‬USD
‪18.51 M‬USD
‪2.73 M‬
Beta (1Y)
4.24

About TriSalus Life Sciences, Inc.

CEO
Mary T. Szela
Headquarters
Westminster
Employees (FY)
112
Founded
2020
FIGI
BBG00Z1HTTT7
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.